340 related articles for article (PubMed ID: 30259253)
1. Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management.
Mathew RC; Löffler AI; Salerno M
Curr Cardiol Rep; 2018 Sep; 20(11):119. PubMed ID: 30259253
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cardiac valvular regurgitant lesions by cardiac MRI sequences: comparison of a four-valve semi-quantitative versus quantitative approach.
Reddy ST; Shah M; Doyle M; Thompson DV; Williams RB; Yamrozik J; Biederman RW
J Heart Valve Dis; 2013 Jul; 22(4):491-9. PubMed ID: 24224411
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance imaging in the assessment of valvular heart disease].
Gallego P
Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():10-8. PubMed ID: 21807283
[TBL] [Abstract][Full Text] [Related]
4. Functional valve assessment: the emerging role of cardiovascular magnetic resonance.
Shah DJ
Methodist Debakey Cardiovasc J; 2010; 6(1):15-9. PubMed ID: 20360653
[TBL] [Abstract][Full Text] [Related]
5. Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease.
Blanken CPS; Farag ES; Boekholdt SM; Leiner T; Kluin J; Nederveen AJ; van Ooij P; Planken RN
J Magn Reson Imaging; 2018 Aug; 48(2):318-329. PubMed ID: 30134000
[TBL] [Abstract][Full Text] [Related]
6. The role of cardiac magnetic resonance in valvular heart disease.
Lopez-Mattei JC; Shah DJ
Methodist Debakey Cardiovasc J; 2013; 9(3):142-8. PubMed ID: 24066197
[TBL] [Abstract][Full Text] [Related]
7. Assessment of valvular heart disease by magnetic resonance imaging.
Globits S; Higgins CB
Am Heart J; 1995 Feb; 129(2):369-81. PubMed ID: 7832111
[TBL] [Abstract][Full Text] [Related]
8. Role of Cardiovascular Magnetic Resonance in Native Valvular Regurgitation: A Comprehensive Review of Protocols, Grading of Severity, and Prediction of Valve Surgery.
Vermes E; Iacuzio L; Levy F; Bohbot Y; Renard C; Gerber B; Maréchaux S; Tribouilloy C
Front Cardiovasc Med; 2022; 9():881141. PubMed ID: 35872899
[TBL] [Abstract][Full Text] [Related]
9. Use of Cardiac Magnetic Resonance Imaging in Assessing Mitral Regurgitation: Current Evidence.
Uretsky S; Argulian E; Narula J; Wolff SD
J Am Coll Cardiol; 2018 Feb; 71(5):547-563. PubMed ID: 29406861
[TBL] [Abstract][Full Text] [Related]
10. [Value of transesophageal echocardiography in diagnosis of diseases of native heart valves].
Niedermeyer J; Daniel WG
Herz; 1993 Dec; 18(6):329-40. PubMed ID: 8307550
[TBL] [Abstract][Full Text] [Related]
11. Advances in noninvasive assessment of valvular heart disease.
Flachskampf FA; Lethen H
Curr Opin Cardiol; 1995 Mar; 10(2):102-6. PubMed ID: 7787274
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantification of valvular heart disease with dynamic cardiac MR imaging.
Didier D; Ratib O; Lerch R; Friedli B
Radiographics; 2000; 20(5):1279-99; discussion 1299-301. PubMed ID: 10992018
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of aortic regurgitation with cardiac magnetic resonance imaging: a systematic review.
Lee JC; Branch KR; Hamilton-Craig C; Krieger EV
Heart; 2018 Jan; 104(2):103-110. PubMed ID: 28822982
[TBL] [Abstract][Full Text] [Related]
14. Assessment of valvular heart disease by cardiovascular magnetic resonance imaging: a review.
Christiansen JP; Karamitsos TD; Myerson SG
Heart Lung Circ; 2011 Feb; 20(2):73-82. PubMed ID: 20956088
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular magnetic resonance imaging for valvular heart disease.
Morello A; Gelfand EV
Curr Heart Fail Rep; 2009 Sep; 6(3):160-6. PubMed ID: 19723457
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in valvular heart disease: clinical application and current role for patient management.
Sommer G; Bremerich J; Lund G
J Magn Reson Imaging; 2012 Jun; 35(6):1241-52. PubMed ID: 22588991
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of primary mitral regurgitation using left ventricular volumes obtained with new automated three-dimensional transthoracic echocardiographic software: A comparison with 3-Tesla cardiac magnetic resonance.
Levy F; Marechaux S; Iacuzio L; Schouver ED; Castel AL; Toledano M; Rusek S; Dor V; Tribouilloy C; Dreyfus G
Arch Cardiovasc Dis; 2018; 111(8-9):507-517. PubMed ID: 29610031
[TBL] [Abstract][Full Text] [Related]
18. CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes.
Myerson SG
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2020-2032. PubMed ID: 33248967
[TBL] [Abstract][Full Text] [Related]
19. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper.
Lancellotti P; Pibarot P; Chambers J; La Canna G; Pepi M; Dulgheru R; Dweck M; Delgado V; Garbi M; Vannan MA; Montaigne D; Badano L; Maurovich-Horvat P; Pontone G; Vahanian A; Donal E; Cosyns B;
Eur Heart J Cardiovasc Imaging; 2022 Apr; 23(5):e171-e232. PubMed ID: 35292799
[TBL] [Abstract][Full Text] [Related]
20. Valvular regurgitation: does cardiovascular magnetic resonance provide additional information compared to echocardiography?
Cawley PJ; Otto CM
Minerva Cardioangiol; 2009 Aug; 57(4):521-35. PubMed ID: 19763073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
